期刊文献+

内源性一氧化氮合酶抑制物及其水解酶变化与子痫前期发病的关系 被引量:1

Relationship between changes of endogenous nitric oxide synthase inhibitor and hydrolase and initiation of pre-eclampsia
原文传递
导出
摘要 目的探讨子痫前期孕妇血浆内源性一氧化氮合酶抑制物——非对称性二甲基精氨酸(ADMA)的水平变化及胎盘组织中一氧化氮合酶抑制物水解酶——二甲基精氨酸二甲胺水解酶2(DDAH-2)的表达变化与子痫前期发病的关系。方法选择2004年1月至2005年1月在广州医学院第三附属医院住院分娩的子痫前期孕妇30例(子痫前期组),以同期正常晚期妊娠妇女10例(正常妊娠组)为对照。采用高效液相色谱(HPLC)分析法测定两组孕妇血浆ADMA水平;采用荧光定量PCR技术检测两组孕妇胎盘组织中DDAH-2 mRNA的表达。结果(1)血浆ADMA水平:子痫前期组孕妇血浆ADMA水平为(18.0±7.2)mg/L,高于正常妊娠组的(10.3±1.7)mg/L,两组比较,差异有统计学意义(P〈0.01);子痫前期组中,发病孕周〈34周者血浆ADMA水平为(22.0±7.0)mg/L,显著高于发病孕周≥34周者的(12.7±2.8)mg/L,两者比较,差异也有统计学意义(P〈0.01)。(2)胎盘组织DDAH-2mRNA的表达量:子痫前期组胎盘组织中DDAH-2 mRNA的表达量为1×10^(5.23±0.45)copy/μl,显著低于正常妊娠组的1×10^(5.65±0.08)copy/μl,两组比较,差异有统计学意义(P〈0.01);子痫前期组中,发病孕周〈34周者胎盘组织DDAH-2mRNA表达量为1×10^(5.02±0.46)copy/μl,显著低于发病孕周≥34周者的1×10^(5.61±0.19)copy/μl,两者比较,差异也有统计学意义(P〈0.01)。结论胎盘组织中DDAH-2mRNA的低表达与血浆ADMA水平的升高,可能与子痫前期的发病有关。 Objective To investigate the role of dimethylarginine dimethylaminohydrolase-2(DDAH-2)/asymmetric dimethylarginine (ADMA) in pathophiology of preeclampsia by detecting expression of DDAH-2 in placenta and serum plasma ADMA. Methods From Jan. 2004 to Jan. 2005, 30 preeelampsia patients (PE group ) were chosen in the Third Affiliated Hospital, Guangzhou Medical College matched with 10 normal third trimester women as control (control group). The placental DDAH-2 mRNA expression was detected by fluorescence quantitative polymerase chain reaction (FQ-PCR) and the plasma concentration of ADMA was determined by high performance liquid chromatography (HPLC). Results ( 1 ) The level of ADMA in PE group was significantly higher that than of control group [ ( 18.0± 7.2)mg/L vs. ( 10. 3 ± 1.7) mg/L, P 〈0. 011- The expression level of ADMA in preeclampsia occurring before 34 gestatinal weeks was significantly higher than that of preeclampsia occurring after 34 gestational weeks [(22.0±7.0) mg/L vs. (12.7±2.8) mg/L, P〈0.01]. (2) The Placental DDAH-2 mRNA expression in preeclampsia patients was remarkably lower than that of control group [ 1 × 10^(5. 23 ±0. 45) copy/μl vs. 1 × 10^(5.65±0.08) copy/μl,P 〈 0. 01 1. The Placental DDAH-2 mRNA in preeclampsia occurring before 34 gestatinal weeks was significantly lower than that of preeclampsia occurring after 34 gestational weeks [1 ×10^(5.02±0.46)copy/μl vs. 1 ×10^(5.61±0.19)copy/μl, P〈0.01]. Conclusion Our results suggested that low expression of DDAH-2 in placenta and increased serum ADMA level might confer the susceptibility to preeelampsia.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2009年第4期249-252,共4页 Chinese Journal of Obstetrics and Gynecology
基金 广东省医学科研基金(A2003644)
关键词 先兆子痫 酰胺基水解酶类 精氨酸 一氧化氮合酶 Pre-eclampsia Amidohydrolases Arginine Nitric oxide synthase
  • 相关文献

参考文献11

  • 1Ayling LJ, Whitley GS, Aplin JD, et al. Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide. Hum Reprod, 2006, 21:2530-2537.
  • 2Jacobi J, Sydow K, von Degenfeld G, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation, 2005,111 : 1431-1438.
  • 3Valkonen VP, Halonen T, Punnonen K. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Analyt Technol Biomed Life Sci, 2005,828:97- 102.
  • 4Smith CL, Birdsey GM, Anthony S, et al. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Biochem Biophys Res Commun, 2003,308:984-989.
  • 5Sawidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet, 2003,361:1511-1517.
  • 6Szuba A, Podgorski M. Asymmetric dimethylargnine(ADMA) a novel cardiovascular risk factor-evidence from epidemiological and prospective clinical trials. Pharmacil Rep,2006,17:2176-2183.
  • 7Perticone F, Sciacqua A, Maio R, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coil Cardiol, 2005,46:518-523.
  • 8Perticone F, Sciacqua A, Maio R, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol, 2005,46:518-523.
  • 9Kim YJ, Park HS, Lee HY, et al. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. Placenta, 2006,27:438-444.
  • 10Rytlewski K, Olszanecki R, Korbut R, et al. Effects of prolonged oral supplementation with 1-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest, 2005,35:32- 37.

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部